| 摘要: |
| 肠道作为机体最大的微生物群系统,肠道内微生物组成和丰度发生改变与机体的健康密切相关。动脉粥样硬化的危险因素(高龄、肥胖、饮食习惯等)诱导肠道生态失衡;肠道微生物代谢产物(短链脂肪酸、三甲胺-N-氧化物等)的改变,诱导动脉粥样硬化的发生和发展。本文就肠道微生物及其代谢产物在动脉粥样硬化中的作用和以肠道为靶点的治疗、干预的研究进展做一综述。 |
| 关键词: 肠道微生物 动脉粥样硬化 短链脂肪酸 三甲胺-N-氧化物 |
| DOI:10.13506/j.cnki.jpr.2020.07.010 |
| 基金项目: |
|
|
|
| Gut microbes-new target for atherosclerosis |
| LI Qing1,WANG Hao1,ZHANG Xiuxiu2,CHEN Dingding1 |
| (1.China Pharmaceutical University,Nanjing 211198,China;2. Jinan Maternal and Child Health Hospital,Jinan 250000,China) |
| Abstract: |
| As the largest microbial community system in the body, the changes of microbial composition and abundance in the intestinal tract are closely related to the health of the body. Risk factors for atherosclerosis (old age, obesity, eating habits, etc.) induce intestinal ecological imbalance.And changes in intestinal microbial metabolites (short-chain fatty acids,trimethylamine-N-oxide, etc.) induce atherosclerosis Occurrence and development. This article reviews the role of intestinal microorganisms and their metabolites in atherosclerosis and the research progress of intestinal targeted therapy and intervention. |
| Key words: Intestinal microbes Atherosclerosis Short-chain fatty acids Trimethylamine -N- oxide |